Endoscopic management of uterine fibroids.

Department of Obstetrics and Gynecology, McGill University, 687 Pine Avenue West, Montreal, Quebec H3A 1A1, Canada.
Bailli&egrave re s Best Practice and Research in Clinical Obstetrics and Gynaecology (Impact Factor: 3). 09/2008; 22(4):707-16. DOI: 10.1016/j.bpobgyn.2008.01.011
Source: PubMed

ABSTRACT Uterine fibroids are the most common benign tumours of the uterus. Management depends on the symptoms, location and size of the fibroids, and the patient's desire to conceive. Surgical management of uterine fibroids has changed from laparotomy to minimally invasive surgery. Uterine fibroids are usually asymptomatic and do not require treatment. Laparoscopic myomectomy is the best treatment option for symptomatic women with uterine fibroids who wish to maintain their fertility. The authors' criteria for laparoscopic myomectomy are a fibroid of <15 cm in size, and no more than three fibroids with a size of 5 cm. Compared with laparotomy, laparoscopic myomectomy has the advantages of small incisions, short hospital stay, less postoperative pain, rapid recovery and good assessment of other abdominal organs. Due to the concern of decreased ovarian reserve, uterine artery embolization is not advisable for these women. In addition, it is associated with high risks of miscarriages, preterm delivery and postpartum bleeding. Laparoscopic myolysis causes severe adhesion formation. Women with submucous fibroids receive myomectomy by hysteroscopy. For women who have completed their family, laparoscopic hysterectomy could be performed. Most fibroids can be managed endoscopically either by laparoscopy or hysteroscopy. Surgeon expertise, especially laparoscopic suturing, is crucial. Laparoscopic myomectomy is still the best treatment option for symptomatic women with uterine fibroids who wish to maintain their fertility. Hysteroscopic myomectomy is an established surgical procedure for women with excessive uterine bleeding, infertility or repeated miscarriages.

  • Source
    Zdrav Vest. 10/2014;
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Objetivo: hacer una revisión sobre la actividad biológica y mecanismo de acción de los sellantes de fibrina en ginecología laparoscópica.
    Revista colombiana de obstetricia y ginecología 12/2011; 62(4):321-325.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Uterine myomas are the main cause for gynecological disease in premenopausal women. If a myomectomy is indicated, abdominal myomectomy is still a frequently performed procedure although laparoscopic myomectomy should be the method of choice. Searches were conducted in PubMed and The Cochrane Library to identify relevant literature. Compared with myomectomy by laparotomy and minilaparotomy, laparoscopic myomectomy is associated with improved short-term outcomes. Laparoscopy is further associated with less adhesion formation. Pregnancy rates after myomectomy in symptomatic patients might be higher after laparoscopy than after laparotomy. Although uterine ruptures following laparoscopic myomectomy are described in the literature, it seems to be a rare event. Concerning the recurrence, there is evidence that rates are similar after laparoscopy and laparotomy. Myomectomy by laparoscopy has several advantages over abdominal myomectomy (by conventional laparotomy and minilaparotomy) and should be the standard procedure. Despite the advantages of laparoscopy, abdominal myomectomy is still a frequently performed procedure. Lack of training in advanced laparoscopic procedures hampers the widespread use of laparoscopic myomectomy. Due to the advantages of laparoscopic surgery, efforts should be made to implement this procedure into daily practice. To provide the best care, physicians should offer patients the opportunity of a laparoscopic treatment of myomas.
    Gynecology and Minimally Invasive Therapy. 05/2014;